aDivision of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada bDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine ...
Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...
Bayer BAYN-0.85%decrease; red down pointing triangle said the Federal Court of Australia closed the last pending case in the country over whether its Roundup weedkiller causes cancer, a win for ...
In the United States, Bayer will continue its multipronged strategy to significantly contain the Roundupâ„¢ litigation. Having achieved favorable outcomes in 15 of the last 22 trials, the company ...
Aspirin use was associated with lower PC risk in both time-dependent (aHR: 0.58; 95% CI 0.49 to 0.69) and PS matching analysis (aHR: 0.61; 95% CI 0.48 to 0.77). An inverse relationship was observed ...
Additionally, the ophthalmology drug Eyleaâ„¢ saw an 8.6% increase in sales. However, these positive developments were offset by a 23% decline in sales of Xarelto, which is Bayer's blockbuster ...